Patents by Inventor Jacob Drew Edick

Jacob Drew Edick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210137709
    Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy. The bioerodible magnesium alloy has magnesium and one or more additional alloying elements, including aluminum. The alloy has a microstructure comprising equiaxed Mg-rich solid solution phase grains having an average grain diameter of less than or equal to 5 microns and continuous or discontinuous second-phase precipitates in grain boundaries between the Mg-rich solid solution-phase grains, the second-phase precipitates having an average longest dimension of 0.5 micron or less.
    Type: Application
    Filed: January 22, 2021
    Publication date: May 13, 2021
    Inventors: Jonathan S. Stinson, Dennis A. Boismier, Jacob Drew Edick, Torsten Scheuermann, Louis Toth, Jan Weber, Charles Deng
  • Patent number: 10589005
    Abstract: A bioerodible endoprosthesis includes a bioerodible body including an alloy comprising at least 85 weight percent magnesium and at least one high-melting-temperature element having a melting temperature of greater than 700° C. The alloy has a microstructure including equiaxed magnesium-rich phase grains and optionally high-melting-temperature intermetallic phases. The equiaxed magnesium-rich phase grains have an average grain diameter of less than or equal to 10 microns. High-melting-temperature intermetallic phases, if present, can have an average longest dimension of 3 microns or less.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: March 17, 2020
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Jacob Drew Edick, Jonathan S. Stinson
  • Patent number: 10518001
    Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy including between 50 weight percent and 92 weight percent magnesium, at least 5.5 weight percent in sum of one or more elements selected from the group consisting of Ho, Er, Lu, Tb and Tm, and at least 2.0 weight percent in sum of one or more elements selected from the group consisting of Y, Nd and Gd. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 15 microns and second-phase precipitates and/or ceramic nanoparticles in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The secondary-phase precipitates or ceramic nanoparticles have an average longest dimension of 2.0 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.
    Type: Grant
    Filed: November 15, 2016
    Date of Patent: December 31, 2019
    Assignee: Boston Scientific Scimed, Inc.
    Inventor: Jacob Drew Edick
  • Patent number: 9603728
    Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 5 microns and second-phase precipitates in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The beta-phase precipitates have an average longest dimension of 0.5 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: March 28, 2017
    Assignee: Boston Scientific SciMed, Inc.
    Inventors: Jonathan S. Stinson, Dennis A. Boismier, Jacob Drew Edick, Torsten Scheuermann, Louis Toth, Jan Webber, Charles Deng
  • Publication number: 20170072112
    Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 5 microns and second-phase precipitates in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The beta-phase precipitates have an average longest dimension of 0.5 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.
    Type: Application
    Filed: November 22, 2016
    Publication date: March 16, 2017
    Inventors: Jonathan S. Stinson, Dennis A. Boismier, Jacob Drew Edick, Torsten Scheuermann, Louis Toth, Jan Weber, Charles Deng
  • Publication number: 20170056562
    Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy including between 50 weight percent and 92 weight percent magnesium, at least 5.5 weight percent in sum of one or more elements selected from the group consisting of Ho, Er, Lu, Tb and Tm, and at least 2.0 weight percent in sum of one or more elements selected from the group consisting of Y, Nd and Gd. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 15 microns and second-phase precipitates and/or ceramic nanoparticles in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The secondary-phase precipitates or ceramic nanoparticles have an average longest dimension of 2.0 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.
    Type: Application
    Filed: November 15, 2016
    Publication date: March 2, 2017
    Inventor: Jacob Drew Edick
  • Patent number: 9522220
    Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy including between 50 weight percent and 92 weight percent magnesium, at least 5.5 weight percent in sum of one or more elements selected from the group consisting of Ho, Er, Lu, Tb and Tm, and at least 2.0 weight percent in sum of one or more elements selected from the group consisting of Y, Nd and Gd. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 15 microns and second-phase precipitates and/or ceramic nanoparticles in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The secondary-phase precipitates or ceramic nanoparticles have an average longest dimension of 2.0 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.
    Type: Grant
    Filed: October 29, 2014
    Date of Patent: December 20, 2016
    Assignee: Boston Scientific SciMed, Inc.
    Inventor: Jacob Drew Edick
  • Patent number: 9446174
    Abstract: A bioerodible endoprosthesis includes a composite including a matrix comprising a bioerodible magnesium alloy and a plurality of ceramic nanoparticles within the matrix. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 5 microns. The microstructure can be produced by one or more equal-channel high-strain processes.
    Type: Grant
    Filed: August 11, 2014
    Date of Patent: September 20, 2016
    Assignee: Boston Scientific SciMed, Inc.
    Inventors: Jan Weber, Jacob Drew Edick
  • Publication number: 20160263288
    Abstract: A bioerodible endoprosthesis includes a bioerodible body including an alloy comprising at least 85 weight percent magnesium and at least one high-melting-temperature element having a melting temperature of greater than 700° C. The alloy has a microstructure including equiaxed magnesium-rich phase grains and optionally high-melting-temperature intermetallic phases. The equiaxed magnesium-rich phase grains have an average grain diameter of less than or equal to 10 microns. High-melting-temperature intermetallic phases, if present, can have an average longest dimension of 3 microns or less.
    Type: Application
    Filed: March 11, 2016
    Publication date: September 15, 2016
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Jacob Drew Edick, Jonathan S. Stinson
  • Publication number: 20150297382
    Abstract: A stent delivery catheter comprising at least one catheter shaft, the catheter shaft having an inner surface and an outer surface and a distal end and a proximal end, the catheter shaft defining a guidewire lumen, the guidewire lumen comprising a diameter defined by the inner surface of the catheter shaft, a stent disposed within the distal end of the catheter shaft and in contact with the inner surface of the catheter shaft, and a stylet disposed within the distal end of the catheter shaft, the stylet comprising a wave geometry.
    Type: Application
    Filed: April 20, 2015
    Publication date: October 22, 2015
    Applicant: Boston Scientific Scimed Inc.
    Inventors: Anthony Frank Tassoni, JR., Martin R. Willard, Patrick A. Haverkost, Jonathan S. Stinson, Peter G. Edelman, Jacob Drew Edick
  • Publication number: 20150157767
    Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy including between 50 weight percent and 92 weight percent magnesium, at least 5.5 weight percent in sum of one or more elements selected from the group consisting of Ho, Er, Lu, Tb and Tm, and at least 2.0 weight percent in sum of one or more elements selected from the group consisting of Y, Nd and Gd. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 15 microns and second-phase precipitates and/or ceramic nanoparticles in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The secondary-phase precipitates or ceramic nanoparticles have an average longest dimension of 2.0 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.
    Type: Application
    Filed: October 29, 2014
    Publication date: June 11, 2015
    Inventor: Jacob Drew Edick
  • Publication number: 20150066135
    Abstract: A bioerodible endoprosthesis includes a composite including a matrix comprising a bioerodible magnesium alloy and a plurality of ceramic nanoparticles within the matrix. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 5 microns. The microstructure can be produced by one or more equal-channel high-strain processes.
    Type: Application
    Filed: August 11, 2014
    Publication date: March 5, 2015
    Inventors: Jan Weber, Jacob Drew Edick
  • Publication number: 20140236284
    Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 5 microns and second-phase precipitates in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The beta-phase precipitates have an average longest dimension of 0.5 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.
    Type: Application
    Filed: February 12, 2014
    Publication date: August 21, 2014
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Jonathan S. Stinson, Dennis A. Boismier, Jacob Drew Edick, Torsten Scheuermann, Louis Toth, Jan Webber, Charles Deng